Clinical Trials
4 trialsNCT05043402 2022-08-15
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
OncXerna Theraputics, Inc.
Phase 3 Unknown
NCT03030287 2020-09-03
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
Mereo BioPharma
Phase 1 Completed
NCT02298387 2020-08-11
A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
Mereo BioPharma
Phase 1 Completed
NCT03035253 2020-08-11
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
Mereo BioPharma
Phase 1 Terminated